- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03014362
TMS for Suicidal Crisis in Active Duty SMs (TMS4SI)
Utility of Repetitive Transcranial Magnetic Stimulation (TMS) in Promoting Rapid Psychiatric Stabilization in Acutely Suicidal Military Service Members
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30905
- Eisenhower Army Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All Active Duty SMs (regardless of sex, ethnicity, sexual or religious orientation) who are admitted to Eisenhower Army Medical Center (EAMC) Inpatient Psychiatric Service (IPS) with active suicidality or elevated risk for suicide regardless of most psychiatric diagnostic co-morbidity (see exclusion criteria). This includes in-patient admissions for suicidality and outpatient SMs with a Columbia-Suicide Severity Rating Scale (C-SSRS) score ≥3.
- Age 18 to 60
- Able to speak and read English.
Exclusion Criteria:
- Combative with staff.
- Comatose/catatonia.
- Incapacity owing to active mania or psychosis.
- Epilepsy, multiple sclerosis, or cerebrovascular accident.
- Non-removable metal in the head (Shrapnel; plates, aneurysm coils/clips; metal tattoos etc.)
- Implantable devices (pacemakers, stimulators, etc.)
- Schizophrenic or borderline personality.
- Positive screen for pregnancy.
- Already receiving TMS as a treatment for depression.
- Non-English reading and speaking subjects
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: TMS active
Neuronetics NeuroStar XPLOR magnetic stimulator - Active; Localization: Left prefrontal dorsolateral neocortex. Dose Delivery: Figure-8 solid core coil at 120% motor threshold, 10 Hz, 4 second train duration, 10 second interval for 30 minutes. Treatment Dose: ~4k/session, 12-15k/day, 36-45k total pulses. Sessions: 9 in total; 3/day for 3 consecutive days over and above SOC (Standard of Care). |
Localization: Left prefrontal dorsolateral neocortex. Dose Delivery: Figure-8 solid core coil at 120% motor threshold, 10 Hz, 4 second train duration, 10 second interval for 30 minutes. Treatment Dose: ~4k/session, 12-15k/day, 36-45k total pulses. Sessions: 9 in total; 3/day for 3 consecutive days over and above SOC. |
SHAM_COMPARATOR: TMS sham
Neuronetics NeuroStar XPLOR magnetic stimulator - Sham; Localization: Left prefrontal dorsolateral neocortex. Sham Delivery: Figure-8 solid core coil rendered inert via blocking insert. Dose: Zero pulses. Sessions: 9 in total; 3/day for 3 consecutive days over and above SOC. |
Localization: Left prefrontal dorsolateral neocortex.
Sham Delivery: Figure-8 solid core coil rendered inert via blocking insert.
Dose: Zero pulses.
Sessions: 9 in total; 3/day for 3 consecutive days over and above SOC.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Suicidal Ideation (Acute)
Time Frame: Change over the active treatment course ie. the 3 days of active treatment
|
The Beck Scale for Suicidal Ideation (SSI-T) is a 19-item clinician administered scale measuring current suicide ideation (SSI-C), suicide ideation at its worst point in the patient's life (SSI-W), and degree of hopelessness.
The scale has been well validated.
SSI-T scores range from 0-38, with higher scores indicating greater suicide risk.
|
Change over the active treatment course ie. the 3 days of active treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christopher E Hines, MD, Eisenhower Army Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1604023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; University of Michigan; Duke University; US Department... and other collaboratorsUnknownSuicide, Attempted | Suicidal Ideation ActiveUnited States
-
Technische Universität DresdenUnknownDepression | Suicidal Ideation/BehaviorGermany
-
International Islamic University, IslamabadRecruitingImpulsivity | Suicidal Ideation and BehaviorPakistan
-
VA Office of Research and DevelopmentCentral Texas Veterans Health Care SystemRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Ohio State UniversityUniversity of Minnesota; Rutgers UniversityCompletedSuicidal Ideation | SuicidalUnited States
-
Rhode Island HospitalNational Institute of Mental Health (NIMH)Enrolling by invitation
Clinical Trials on Neuronetics NeuroStar XPLOR magnetic stimulator - Active
-
Emory UniversityCompleted
-
Paul E. CroarkinTerminated
-
Butler HospitalNeuronetics; Providence VA Medical CenterCompletedMajor Depressive Disorder | Posttraumatic Stress Disorder | Transcranial Magnetic Stimulation, RepetitiveUnited States
-
James A. Haley Veterans Administration HospitalCompletedDepression | Posttraumatic Stress DisorderUnited States
-
NeuroneticsWithdrawnMajor Depressive DisorderUnited Kingdom
-
Central Arkansas Veterans Healthcare SystemCompletedApathy | Alzheimer's DementiaUnited States
-
Central Arkansas Veterans Healthcare SystemUnknownMild Cognitive Impairment | ApathyUnited States
-
NeuroneticsUnknownMajor Depressive DisorderUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedMajor Depressive DisorderUnited States
-
Cervel Neurotech, Inc.CompletedDepressive Disorder, MajorUnited States